Constellation Pharmaceuticals, Inc. Financial Statements 2011-2024 | CNST

Annual Financial Statements Constellation Pharmaceuticals, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.57 B	933 M	81.6 M	-	-	-	-	-	-	-
Shares	47.5 M	28.2 M	12 M	-	-	-	-	-	-	-
Net Income	-126 M	-85.6 M	-59.9 M	-35.4 M	-34.5 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-
EBITDA	-121 M	-85.3 M	-60.7 M	-34 M	-33 M	-	-	-	-	-
Operating Expenses	125 M	86.1 M	61.2 M	-	-	-	-	-	-	-
General and Administrative Expenses	29.3 M	19.6 M	12.5 M	6.47 M	5.78 M	-	-	-	-	-

All numbers in USD currency